Evidence map›Paper›PMID 22877888›Full record

Trial reportBehaviour research and therapy2012

Visceral sensitivity as a mediator of outcome in the treatment of irritable bowel syndrome.

Kate Wolitzky-Taylor, Michelle G Craske, Jennifer S Labus, Emeran A Mayer, Bruce D Naliboff

Open access · greenAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Behaviour research and therapy, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it, 62 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Observational
  14. Observational
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Kate Wolitzky-TaylorDepartment of Psychology, UCLA, Los Angeles, CA, USA.
Michelle G Craske
Jennifer S Labus
Emeran A Mayer
Bruce D Naliboff
University of California, Los Angeles · USNeurobehavioral Systems · US

Funding

Mind/Brain/Body Interactions in Stress-Related DisordersR24AT002681 · NCCIH · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI MAYER, EMERAN A · 2004 to 2008
$4.6M
Treatment of Fear and Pain in Irritable Bowel SyndromeR01NR007768 · NINR · BRENTWOOD BIOMEDICAL RESEARCH INSTITUTE · PI NALIBOFF, BRUCE D · 2002 to 2006
$1.5M
NCCIH NIH HHS R24 AT002681NINR NIH HHS R01 NR007768
6 · The paper itself

Abstract

Patients with irritable bowel syndrome (IBS) experience anxiety about visceral sensations, leading to avoidance behaviors and hypervigilance that maintain IBS symptoms. The current study used data from a clinical trial that compared a treatment aimed at reducing anxiety about visceral sensations (interoceptive exposure; IE) to an attention control (AC) and a CBT-based stress-management treatment (SM) to examine whether changes in visceral sensitivity mediated IBS symptom and quality of life outcomes. Data from participants who completed one of the three treatments (N = 76) were subjected to mediation analyses. Visceral sensitivity mediated treatment outcomes across all outcome measures and across all treatment groups, with no differences between IE and the other treatment groups. This finding suggests that psychosocial treatments for IBS may work by decreasing visceral sensitivity, and the degree to which visceral sensitivity is decreased is related to outcome, suggesting IE may be the preferable treatment option.

Indexed as

Cognitive Behavioral TherapyAdultAnxietyAttentionAttitude to HealthFeeding BehaviorFemaleHumansIrritable Bowel SyndromeMaleQuality of LifeStress, PsychologicalTreatment OutcomeViscera

Identifiers

PMID22877888
PMCPMC4226616
OpenAlexW2039606535

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.